ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) has released an update.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has announced changes to its supervisory committee, with Mr. Gu Jiefeng resigning due to other business commitments, effective July 29, 2024, and Ms. Zhang Wei being elected as the new employee representative supervisor. Ms. Zhang, with a strong background in bioengineering, has been with the company since 2013 and holds an indirect interest in the company’s share capital.
For further insights into HK:1541 stock, check out TipRanks’ Stock Analysis page.
